Proscia Raises $23M in Series B Funding Led by Scale Venture Partners

Steve Holloway headshot
Steve Holloway
Published: December 1, 2020 In The News

December 1, 2020 – Proscia, a leading provider of digital and computational pathology solutions, has secured $23 million in Series B funding led by Scale Venture Partners, with participation from Hitachi Ventures, the strategic corporate venture capital arm of Hitachi, Ltd., bringing its funding total to $35 million. The company will use the investment to accelerate its global growth and strengthen its position of leadership in transforming cancer research and diagnosis at a time when demand for modernizing pathology is higher than ever.